Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Melzi

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The Review of Diabetic Studies : RDS|July 2, 2011
Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center studyPaola Maffi, Marina Scavini, Carlo Socci, et al.
Scientific Reports|October 27, 2017
miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFAIlaria Marzinotto, Silvia Pellegrini, Cristina Brigatti, et al.
Frontiers in Endocrinology|July 6, 2023
<i>Post hoc</i> analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of respondersValeria Sordi, Paolo Monti, Vito Lampasona, et al.
Blood|September 24, 2009
Bone marrow as an alternative site for islet transplantationElisa Cantarelli, Raffaella Melzi, Alessia Mercalli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 4, 2025
Comparative Analysis of Islet Auto-Transplantation Outcome Classification Systems: Evaluating Concordance, Feasibility, and a Data-Driven ApproachDavide Catarinella, Paola Magistretti, Raffaella Melzi, et al.
Biology|August 27, 2021
Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 PneumoniaAndrea Laurenzi, Amelia Caretto, Chiara Molinari, et al.
Blood|March 24, 2005
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic isletsValeria Sordi, Maria Luisa Malosio, Federica Marchesi, et al.
Transplantation|October 7, 2014
Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1/2 trialPaola Maffi, Thierry Berney, Rita Nano, et al.
The Journal of Clinical Investigation|September 22, 2012
CXCR1/2 inhibition enhances pancreatic islet survival after transplantationAntonio Citro, Elisa Cantarelli, Paola Maffi, et al.
The Lancet. Diabetes & Endocrinology|February 10, 2025
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in ItalyDavide Catarinella, Raffaella Melzi, Alessia Mercalli, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Review of Diabetic Studies : RDS|July 2, 2011
Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center studyPaola Maffi, Marina Scavini, Carlo Socci, et al.
Scientific Reports|October 27, 2017
miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFAIlaria Marzinotto, Silvia Pellegrini, Cristina Brigatti, et al.
Frontiers in Endocrinology|July 6, 2023
<i>Post hoc</i> analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of respondersValeria Sordi, Paolo Monti, Vito Lampasona, et al.
Blood|September 24, 2009
Bone marrow as an alternative site for islet transplantationElisa Cantarelli, Raffaella Melzi, Alessia Mercalli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 4, 2025
Comparative Analysis of Islet Auto-Transplantation Outcome Classification Systems: Evaluating Concordance, Feasibility, and a Data-Driven ApproachDavide Catarinella, Paola Magistretti, Raffaella Melzi, et al.
Biology|August 27, 2021
Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 PneumoniaAndrea Laurenzi, Amelia Caretto, Chiara Molinari, et al.
Blood|March 24, 2005
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic isletsValeria Sordi, Maria Luisa Malosio, Federica Marchesi, et al.
Transplantation|October 7, 2014
Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1/2 trialPaola Maffi, Thierry Berney, Rita Nano, et al.
The Journal of Clinical Investigation|September 22, 2012
CXCR1/2 inhibition enhances pancreatic islet survival after transplantationAntonio Citro, Elisa Cantarelli, Paola Maffi, et al.
The Lancet. Diabetes & Endocrinology|February 10, 2025
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in ItalyDavide Catarinella, Raffaella Melzi, Alessia Mercalli, et al.
Pageof 4